Latest Headlines from Nourish | The Nourish Mission

FDA Considers Broader Supplement Rules

What's happened

The FDA held a public meeting to discuss expanding dietary supplement criteria to include non-food substances like peptides. Industry groups oppose stricter regulations, citing potential delays and legal challenges. The move aligns with President Kennedy's push for reform, but faces industry resistance.

What's behind the headline?

The upcoming FDA meeting signals a significant shift in supplement regulation, driven by political support for modernizing the industry. Industry opposition highlights concerns over regulatory delays and legal liabilities, especially regarding the 'generally recognized as safe' (GRAS) process. If the FDA redefines dietary ingredients to include non-food substances, it could accelerate innovation but also provoke lawsuits. Kennedy's support for peptides and loosening restrictions suggests a broader agenda to deregulate health products, potentially benefiting certain industry players aligned with his movement. The outcome will likely reshape the supplement landscape, balancing innovation with regulatory oversight.

How we got here

The FDA's current regulations classify supplements as food, primarily from natural ingredients. Recent wellness products featuring peptides and other non-traditional substances challenge this framework. President Kennedy's administration aims to modernize supplement oversight, but industry groups warn that new rules could hinder innovation and lead to legal disputes.

Our analysis

The AP News reports that the FDA's public meeting is the first since Robert F. Kennedy Jr. became the top health official, with Kennedy advocating for easing restrictions on supplements and peptides. The Independent emphasizes industry pushback, warning that new regulations could slow innovation and lead to legal challenges, citing lawyers who argue that FDA's current slow process is problematic. The New York Times highlights the political support Kennedy has garnered for reform, but notes the strong resistance from industry groups concerned about regulatory overreach and legal liabilities, especially regarding the 'generally recognized as safe' designation and ingredient approval processes.

More on these topics


Latest Headlines from Nourish | The Nourish Mission